Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
2
The company has declared Negative results for the last 3 consecutive quarters
3
With ROE of 10.56%, it has a Very Expensive valuation with a 1.02 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.26%
0%
-3.26%
6 Months
-7.29%
0%
-7.29%
1 Year
-16.04%
0%
-16.04%
2 Years
-25.83%
0%
-25.83%
3 Years
-28.23%
0%
-28.23%
4 Years
-32.58%
0%
-32.58%
5 Years
-10.1%
0%
-10.1%
Kato (Hong Kong) Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.09%
EBIT Growth (5y)
-0.28%
EBIT to Interest (avg)
11.45
Debt to EBITDA (avg)
0.84
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
0.68
Tax Ratio
33.94%
Dividend Payout Ratio
91.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.98%
ROE (avg)
23.47%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.02
EV to EBIT
9.43
EV to EBITDA
5.39
EV to Capital Employed
1.01
EV to Sales
1.96
PEG Ratio
NA
Dividend Yield
449.44%
ROCE (Latest)
10.75%
ROE (Latest)
10.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
317.10
271.30
16.88%
Operating Profit (PBDIT) excl Other Income
115.10
104.90
9.72%
Interest
15.60
12.10
28.93%
Exceptional Items
-25.00
18.60
-234.41%
Consolidate Net Profit
21.10
64.10
-67.08%
Operating Profit Margin (Excl OI)
207.60%
211.00%
-0.34%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 16.88% vs -33.55% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -67.08% vs -49.05% in Mar 2024
About Kato (Hong Kong) Holdings Ltd. 
Kato (Hong Kong) Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






